RecruitingNot ApplicableNCT07147647

Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma

Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Intraocular Pressure in Non-Caucasian Open Angle Glaucoma Patients

Sponsor

Select Eye Care

Enrollment

60 participants

Start Date

Jul 16, 2025

Study Type

INTERVENTIONAL

Conditions

Primary Open Angle Glaucoma (POAG)

Summary

The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a laser eye treatment called Direct Selective Laser Trabeculoplasty (DSLT) for lowering eye pressure in Black African patients with open-angle glaucoma. Glaucoma is a condition where high pressure in the eye can damage vision. **You may be eligible if...** - You are an adult of Black African descent - You have been diagnosed with mild to moderate primary open-angle glaucoma - You are scheduled to undergo DSLT treatment - Your eye pressure at the time of the procedure is between 21 and 32 mmHg **You may NOT be eligible if...** - You have had previous eye surgery or laser treatment for glaucoma - You have a secondary form of glaucoma (caused by another condition) - You were on eye pressure-lowering medications and did not complete the required washout period Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.